- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04482530
Food Matrices Based on Fruit Pastes as Vectors of Carbohydrates for the Prevention and Management of Protein-energy Undernutrition in the Elderly (Fruisenior) (Fruisenior)
Food Matrices Based on Fruit Pastes as Vectors of Carbohydrates for the Prevention and Management of Protein-energy Undernutrition in the Elderly: Proof of Clinical Concept
Study Overview
Detailed Description
This is an interventional randomized, single blinded, cross over and controlled study.
The main objective is the study of the kinetic modification of blood glucose with the "fruit" matrices enriched in maltodextrins, fructose and isomaltulose compared to the original recipe consisting only of simple sugars.
The secondary objective is:
-the assessment of the acceptability of all the fruit pastes tested (organoleptic, satiety and gastrointestinal comfort aspects).The study is composed of 7 visits Visit 1 - Selection Visit (Day -7)
- Informed consent form
- Clinical examination
- Medical history
- Anthropometric characteristics
- Blood biochemical and hematological assessment
- Compliance test with the original matrix will be carried out
Visit 2 (D0) / Visit 3 (D7) / Visit 4 (D14) / Visit 5 (D21) / Visit 6 (D28): study period If all the biological criteria are respected, the subjects will have to come back to the clinical center for each of the 5 study periods.
Volunteers will arrive fasted, without smoking in the morning. A catheter will be placed for blood sampling. After a first blood sampling for basal values, volunteers will ingest the equivalent of two bars of fruit pastes (about 80g in 10 minutes maximum) and blood will be withdrawn 15, 30, 45, 60, 90, 120 and 180 minutes after ingestion. The different matrices (5 in total) will be tested on the same volunteer. Plasma samples will be used to determine plasma glucose and fructose concentrations (aliquots stored in center for later assays) to evaluate the postprandial profiles of these two nutrients. At the end of the kinetic, the volunteers will be offered a complete meal. A satiety questionnaire will be performed before then 60 and 180 min after the ingestion of each fruit matrix. A questionnaire of satisfaction and acceptability will also be realized during the consumption of the matrix.
After the 5 fruit matrix will be tested, the subject will be invited to participate in an individual interview of about 30-45min with a member of the project team. The purpose of this interview will be a qualitative approach to search for a food development that can could improve the sensory quality of the fruit pastes tested and intended for the elderly (see below).
Visit 7 (D35 to D40): Participation in a discussion group (about 2 hours). During the participation in this group all 10 participants will be invited to taste the 5 products (original recipe, maltodextrin recipe, fructose recipe, isomaltulose recipe and mixed recipe comprising fructose and isomaltulose). Participants will be asked to indicate for each product their degree of appreciation for these products, their possible defects and qualities and to suggest ideas for improving their taste / texture / appearance. These interviews will alternate individual reflection phases and discussion phases according to the focus group method.
Visit 7 will be the last visit of the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63000
- CHU de Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male subject
- Subject over 65 years (included)
- Subject over 61 kg (included)
- Able to consume the 80g of fruit pastes in 10 minutes
- Subject with a dentition consistent with the fruit paste consumption in 10 minutes
- Subject with a Body Mass Index (BMI) between 21 and 30 kg/m2
- Subject agreeing to provide written consent
Exclusion Criteria:
- Subject with acute pathology (unstable or terminal pathology, severe dementia)
- Subject with renal failure (clearance < 60 ml/min)
- Subject with metabolic syndrome (3 of the following 5 criteria: waist greater than 94 cm, blood triglyceride greater than 1.7 mmol/l, blood pressure greater than or equal to 130 mm Hg/85 mm Hg, cholesterol (HDL) less than 1.0 mmol/l in men, blood glucose greater than or equal to 5.6 mmol/l)
- Person with diabetes
- Subject on food restriction
- Subject undergoing chemotherapy
- Subject with gastrointestinal pathology
- Subject in a diet incompatible with the nutritional protocol (gluten, lactose or milk intolerance, vegan)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Original recipe
Normal fruit paste
|
Evaluation of the kinetics of the appearance of nutrients and the metabolic response induced by the consumption of fruit pastes (5 different matrices will be tested: 1 Original recipe, 1 maltodextrine recipe, 1 fructose recipe, 1 isomaltulose recipe and 1 mixed recipe comprising fructose and isomaltulose) in elderly healthy volunteers.
|
Experimental: maltodextrin recipe
fruit pastes in which some of the simple sugars in the recipe will be replaced by maltodextrin with a low glycemic index (DE12).
|
Evaluation of the kinetics of the appearance of nutrients and the metabolic response induced by the consumption of fruit pastes (5 different matrices will be tested: 1 Original recipe, 1 maltodextrine recipe, 1 fructose recipe, 1 isomaltulose recipe and 1 mixed recipe comprising fructose and isomaltulose) in elderly healthy volunteers.
|
Experimental: fructose recipe
fruit pastes in which some of the simple sugars in the recipe (25% min) will be replaced by fructose
|
Evaluation of the kinetics of the appearance of nutrients and the metabolic response induced by the consumption of fruit pastes (5 different matrices will be tested: 1 Original recipe, 1 maltodextrine recipe, 1 fructose recipe, 1 isomaltulose recipe and 1 mixed recipe comprising fructose and isomaltulose) in elderly healthy volunteers.
|
Experimental: isomaltulose recipe
fruit pastes with some of the sugars will be replaced (25% min) by isomaltulose
|
Evaluation of the kinetics of the appearance of nutrients and the metabolic response induced by the consumption of fruit pastes (5 different matrices will be tested: 1 Original recipe, 1 maltodextrine recipe, 1 fructose recipe, 1 isomaltulose recipe and 1 mixed recipe comprising fructose and isomaltulose) in elderly healthy volunteers.
|
Experimental: mixed recipe
fruit pastes with some of the sugars will be replaced (25% min) by fructose / isomaltulose
|
Evaluation of the kinetics of the appearance of nutrients and the metabolic response induced by the consumption of fruit pastes (5 different matrices will be tested: 1 Original recipe, 1 maltodextrine recipe, 1 fructose recipe, 1 isomaltulose recipe and 1 mixed recipe comprising fructose and isomaltulose) in elderly healthy volunteers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area Under the Curve (AUC) of glycemia
Time Frame: Day 0
|
Area Under the Curve (AUC) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Maximum Plasma Concentration (Cmax) of glycemia
Time Frame: Day 0
|
Maximum Plasma Concentration (Cmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Time of Maximum Plasma Concentration (Tmax) of glycemia
Time Frame: Day 0
|
Time of Maximum Plasma Concentration (Tmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Area Under the Curve (AUC) of glycemia
Time Frame: Day 7
|
Area Under the Curve (AUC) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Maximum Plasma Concentration (Cmax) of glycemia
Time Frame: Day 7
|
Maximum Plasma Concentration (Cmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Time of Maximum Plasma Concentration (Tmax) of glycemia
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Area Under the Curve (AUC) of glycemia
Time Frame: day 14
|
Area Under the Curve (AUC) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Maximum Plasma Concentration (Cmax) of glycemia
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of glycemia
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Area Under the Curve (AUC) of glycemia
Time Frame: day 21
|
Area Under the Curve (AUC) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Maximum Plasma Concentration (Cmax) of glycemia
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of glycemia
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of glycemia
Time Frame: day 28
|
Area Under the Curve (AUC) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Maximum Plasma Concentration (Cmax) of glycemia
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of glycemia
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of glycemia (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area Under the Curve (AUC) of fructose
Time Frame: Day 0
|
Area Under the Curve (AUC) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Maximum Plasma Concentration (Cmax) of fructose
Time Frame: Day 0
|
Maximum Plasma Concentration (Cmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Time of Maximum Plasma Concentration (Tmax) of fructose
Time Frame: Day 0
|
Time of Maximum Plasma Concentration (Tmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Area Under the Curve (AUC) of fructose
Time Frame: Day 7
|
Area Under the Curve (AUC) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste
|
Day 7
|
Maximum Plasma Concentration (Cmax) of fructose
Time Frame: Day 7
|
Maximum Plasma Concentration (Cmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Time of Maximum Plasma Concentration (Tmax) of fructose
Time Frame: Day 7
|
Time of Maximum Plasma Concentration (Tmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Area Under the Curve (AUC) of fructose
Time Frame: Day 14
|
Area Under the Curve (AUC) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Maximum Plasma Concentration (Cmax) of fructose
Time Frame: Day 14
|
Maximum Plasma Concentration (Cmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Time of Maximum Plasma Concentration (Tmax) of fructose
Time Frame: Day 14
|
Time of Maximum Plasma Concentration (Tmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Area Under the Curve (AUC) of fructose
Time Frame: Day 21
|
Area Under the Curve (AUC) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste
|
Day 21
|
Maximum Plasma Concentration (Cmax) of fructose
Time Frame: Day 21
|
Maximum Plasma Concentration (Cmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Time of Maximum Plasma Concentration (Tmax) of fructose
Time Frame: Day 21
|
Time of Maximum Plasma Concentration (Tmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Area Under the Curve (AUC) of fructose
Time Frame: Day 28
|
Area Under the Curve (AUC) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste
|
Day 28
|
Maximum Plasma Concentration (Cmax) of fructose
Time Frame: Day 28
|
Maximum Plasma Concentration (Cmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Time of Maximum Plasma Concentration (Tmax) of fructose
Time Frame: Day 28
|
Time of Maximum Plasma Concentration (Tmax) of fructose (defined in g/L) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Area Under the Curve (AUC) of glucagon
Time Frame: day 0
|
Area Under the Curve (AUC) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Maximum Plasma Concentration (Cmax) of glucagon
Time Frame: day 0
|
: Maximum Plasma Concentration (Cmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of glucagon
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of glucagon
Time Frame: day 7
|
Area Under the Curve (AUC) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of glucagon
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of glucagon
Time Frame: Day 7
|
Time of Maximum Plasma Concentration (Tmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 7
|
Area Under the Curve (AUC) of glucagon
Time Frame: Day 14
|
Area Under the Curve (AUC) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 14
|
Maximum Plasma Concentration (Cmax) of glucagon
Time Frame: Day 14
|
Maximum Plasma Concentration (Cmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Time of Maximum Plasma Concentration (Tmax) of glucagon
Time Frame: Day 14
|
Time of Maximum Plasma Concentration (Tmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 14
|
Area Under the Curve (AUC) of glucagon
Time Frame: Day 21
|
Area Under the Curve (AUC) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Maximum Plasma Concentration (Cmax) of glucagon
Time Frame: Day 21
|
Maximum Plasma Concentration (Cmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Time of Maximum Plasma Concentration (Tmax) of glucagon
Time Frame: Day 21
|
Time of Maximum Plasma Concentration (Tmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Area Under the Curve (AUC) of glucagon
Time Frame: Day 28
|
Area Under the Curve (AUC) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 28
|
Maximum Plasma Concentration (Cmax) of glucagon
Time Frame: Day 28
|
Maximum Plasma Concentration (Cmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Time of Maximum Plasma Concentration (Tmax) of glucagon
Time Frame: Day 28
|
Time of Maximum Plasma Concentration (Tmax) of glucagon (defined in np/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Area Under the Curve (AUC) of CCK
Time Frame: Day 0
|
Area Under the Curve (AUC) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Maximum Plasma Concentration (Cmax) of CCK
Time Frame: Day 0
|
Maximum Plasma Concentration (Cmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 0
|
Time of Maximum Plasma Concentration (Tmax) of CCK
Time Frame: Day 0
|
Time of Maximum Plasma Concentration (Tmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Area Under the Curve (AUC) of CCK
Time Frame: Day 7
|
Area Under the Curve (AUC) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Maximum Plasma Concentration (Cmax) of CCK
Time Frame: Day 7
|
Maximum Plasma Concentration (Cmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 7
|
Time of Maximum Plasma Concentration (Tmax) of CCK
Time Frame: Day 7
|
Time of Maximum Plasma Concentration (Tmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 7
|
Area Under the Curve (AUC) of CCK
Time Frame: Day 14
|
Area Under the Curve (AUC) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Maximum Plasma Concentration (Cmax) of CCK
Time Frame: Day 14
|
Maximum Plasma Concentration (Cmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Time of Maximum Plasma Concentration (Tmax) of CCK
Time Frame: Day 14
|
Time of Maximum Plasma Concentration (Tmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 14
|
Area Under the Curve (AUC) of CCK
Time Frame: Day 21
|
Area Under the Curve (AUC) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 21
|
Maximum Plasma Concentration (Cmax) of CCK
Time Frame: Day 21
|
Maximum Plasma Concentration (Cmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
Day 21
|
Time of Maximum Plasma Concentration (Tmax) of CCK
Time Frame: Day 21
|
Time of Maximum Plasma Concentration (Tmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 21
|
Area Under the Curve (AUC) of CCK
Time Frame: Day 28
|
Area Under the Curve (AUC) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Maximum Plasma Concentration (Cmax) of CCK
Time Frame: Day 28
|
Maximum Plasma Concentration (Cmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Time of Maximum Plasma Concentration (Tmax) of CCK
Time Frame: Day 28
|
Time of Maximum Plasma Concentration (Tmax) of CCK (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 28
|
Area Under the Curve (AUC) of Grehlin
Time Frame: Day 0
|
Area Under the Curve (AUC) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Maximum Plasma Concentration (Cmax) of Grehlin
Time Frame: Day 0
|
Maximum Plasma Concentration (Cmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
Day 0
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of Grehlin
Time Frame: day 7
|
Area Under the Curve (AUC) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of Grehlin
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Area Under the Curve (AUC) of Grehlin
Time Frame: day 14
|
Area Under the Curve (AUC) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Maximum Plasma Concentration (Cmax) of Grehlin
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Area Under the Curve (AUC) of Grehlin
Time Frame: day 21
|
Area Under the Curve (AUC) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of Grehlin
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of Grehlin
Time Frame: day 28
|
Area Under the Curve (AUC) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of Grehlin
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of Grehlin (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Area Under the Curve (AUC) of leptin
Time Frame: day 0
|
Area Under the Curve (AUC) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Maximum Plasma Concentration (Cmax) of leptin
Time Frame: day 0
|
Maximum Plasma Concentration (Cmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of leptin
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of leptin
Time Frame: day 7
|
Area Under the Curve (AUC) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of leptin
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of leptin
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Area Under the Curve (AUC) of leptin
Time Frame: day 14
|
Area Under the Curve (AUC) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Maximum Plasma Concentration (Cmax) of leptin
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of leptin
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Area Under the Curve (AUC) of leptin
Time Frame: day 21
|
Area Under the Curve (AUC) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of leptin
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of leptin
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of leptin
Time Frame: day 28
|
Area Under the Curve (AUC) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of leptin
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of leptin
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of leptin (defined in ng/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Area Under the Curve (AUC) of GLP1
Time Frame: day 0
|
Area Under the Curve (AUC) of GLP1 (defined in pmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Maximum Plasma Concentration (Cmax) of GLP1
Time Frame: day 0
|
Maximum Plasma Concentration (Cmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of GLP1
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of GLP1
Time Frame: day 7
|
Area Under the Curve (AUC) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Maximum Plasma Concentration (Cmax) of GLP1
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of GLP1
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Area Under the Curve (AUC) of GLP1
Time Frame: day 14
|
Area Under the Curve (AUC) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Maximum Plasma Concentration (Cmax) of GLP1
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of GLP1
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Area Under the Curve (AUC) of GLP1
Time Frame: day 21
|
Area Under the Curve (AUC) of GLP1 (defined in pmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of GLP1
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of GLP1 (defined in pmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of GLP1
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of GLP1
Time Frame: day 28
|
Area Under the Curve (AUC) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of GLP1
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of GLP1
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of GLP1 (defined in pmol /L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Area Under the Curve (AUC) of incretines
Time Frame: day 0
|
Area Under the Curve (AUC) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Maximum Plasma Concentration (Cmax) of incretines
Time Frame: day 0
|
Maximum Plasma Concentration (Cmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of incretines
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of incretines
Time Frame: day 7
|
Area Under the Curve (AUC) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of incretines
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of incretines
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Area Under the Curve (AUC) of incretines
Time Frame: day 14
|
Area Under the Curve (AUC) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Maximum Plasma Concentration (Cmax) of incretines
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of incretines
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Area Under the Curve (AUC) of incretines
Time Frame: day 21
|
Area Under the Curve (AUC) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of incretines
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of incretines
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Area Under the Curve (AUC) of incretines
Time Frame: day 28
|
Area Under the Curve (AUC) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of incretines
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of incretines
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of incretines (defined in pg/mL) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Area Under the Curve (AUC) of insulin
Time Frame: day 0
|
Area Under the Curve (AUC) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Maximum Plasma Concentration (Cmax) of insulin
Time Frame: day 0
|
Maximum Plasma Concentration (Cmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of insulin
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of insulin
Time Frame: day 7
|
Area Under the Curve (AUC) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of insulin
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of insulin
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Area Under the Curve (AUC) of insulin
Time Frame: day 14
|
Area Under the Curve (AUC) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Maximum Plasma Concentration (Cmax) of insulin
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of insulin
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Area Under the Curve (AUC) of insulin
Time Frame: day 21
|
Area Under the Curve (AUC) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of insulin
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of insulin
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of insulin
Time Frame: day 28
|
Area Under the Curve (AUC) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of urea (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of insulin
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of insulin (defined in µg/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Area Under the Curve (AUC) of urea
Time Frame: day 0
|
Area Under the Curve (AUC) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 0
|
Maximum Plasma Concentration (Cmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 0
|
Time of Maximum Plasma Concentration (Tmax) of urea
Time Frame: day 0
|
Time of Maximum Plasma Concentration (Tmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 0
|
Area Under the Curve (AUC) of urea
Time Frame: day 7
|
Area Under the Curve (AUC) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 7
|
Maximum Plasma Concentration (Cmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 7
|
Time of Maximum Plasma Concentration (Tmax) of urea
Time Frame: day 7
|
Time of Maximum Plasma Concentration (Tmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 7
|
Area Under the Curve (AUC) of urea
Time Frame: day 14
|
Area Under the Curve (AUC) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 14
|
Maximum Plasma Concentration (Cmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 14
|
Time of Maximum Plasma Concentration (Tmax) of urea
Time Frame: day 14
|
Time of Maximum Plasma Concentration (Tmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 14
|
Area Under the Curve (AUC) of urea
Time Frame: day 21
|
Area Under the Curve (AUC) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 21
|
Maximum Plasma Concentration (Cmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 21
|
Time of Maximum Plasma Concentration (Tmax) of urea
Time Frame: day 21
|
Time of Maximum Plasma Concentration (Tmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 21
|
Area Under the Curve (AUC) of urea
Time Frame: day 28
|
Area Under the Curve (AUC) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Maximum Plasma Concentration (Cmax) of urea
Time Frame: day 28
|
Maximum Plasma Concentration (Cmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste.
|
day 28
|
Time of Maximum Plasma Concentration (Tmax) of urea
Time Frame: day 28
|
Time of Maximum Plasma Concentration (Tmax) of urea (defined in mmol/L) between T0 and T120 minutes following ingestion of fruit paste
|
day 28
|
Questionnaire of satiety
Time Frame: at time 0 after ingestion in Day 0
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 0 after ingestion in Day 0
|
Questionnaire of satiety
Time Frame: at time 60 after ingestion in Day 0
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry
|
at time 60 after ingestion in Day 0
|
Questionnaire of satiety
Time Frame: at time 180 after ingestion in Day 0
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 180 after ingestion in Day 0
|
Questionnaire of satiety
Time Frame: at time 0 after ingestion in Day 7
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry
|
at time 0 after ingestion in Day 7
|
Questionnaire of satiety
Time Frame: at time 60 after ingestion in Day 7
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry
|
at time 60 after ingestion in Day 7
|
Questionnaire of satiety
Time Frame: at time 180 after ingestion in Day 7
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 180 after ingestion in Day 7
|
Questionnaire of satiety
Time Frame: at time 0 after ingestion in Day 14
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 0 after ingestion in Day 14
|
Questionnaire of satiety
Time Frame: at time 60 after ingestion in Day 14
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry
|
at time 60 after ingestion in Day 14
|
Questionnaire of satiety
Time Frame: at time 180 after ingestion in Day 14
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry
|
at time 180 after ingestion in Day 14
|
Questionnaire of satiety
Time Frame: at time 0 after ingestion in Day 21
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 0 after ingestion in Day 21
|
Questionnaire of satiety
Time Frame: at time 60 after ingestion in Day 21
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 60 after ingestion in Day 21
|
Questionnaire of satiety
Time Frame: at time 180 after ingestion in Day 21
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 180 after ingestion in Day 21
|
Questionnaire of satiety
Time Frame: at time 0 after ingestion in Day 28
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 0 after ingestion in Day 28
|
Questionnaire of satiety
Time Frame: at time 60 after ingestion in Day 28
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 60 after ingestion in Day 28
|
Questionnaire of satiety
Time Frame: at time 180 after ingestion in Day 28
|
Questionnaire was composed of 4 questions where satiety was assessed by a 0-10 Numerical Satiety Rating Scale where "0" means to be free from hunger and "10" to be very hungry.
|
at time 180 after ingestion in Day 28
|
Questionnaire of acceptability
Time Frame: day 0
|
Acceptability was assessed by a 7-point time scale where "1" means a very poor acceptability and "7" means a very good acceptability
|
day 0
|
Questionnaire of acceptability
Time Frame: day 7
|
Acceptability was assessed by a 7-point time scale where "1" means a very poor acceptability and "7" means a very good acceptability
|
day 7
|
Questionnaire of acceptability
Time Frame: day 14
|
Acceptability was assessed by a 7-point time scale where "1" means a very poor acceptability and "7" means a very good acceptability
|
day 14
|
Questionnaire of acceptability
Time Frame: day 21
|
Acceptability was assessed by a 7-point time scale where "1" means a very poor acceptability and "7" means a very good acceptability
|
day 21
|
Questionnaire of acceptability
Time Frame: day 28
|
Acceptability was assessed by a 7-point time scale where "1" means a very poor acceptability and "7" means a very good acceptability
|
day 28
|
Facilited individual interview
Time Frame: day 40
|
Facilitated interview to assess organoleptic, satiety and gastrointestinal comfort
|
day 40
|
Focus group
Time Frame: day 40
|
Focus group interview to assess organoleptic, satiety and gastrointestinal comfort
|
day 40
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RBHP 2019 PICKERING
- 2019-A00995-52 (Other Identifier: ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on fruit paste matrice
-
University of CopenhagenDanish Meat Research InstituteCompleted
-
Nahda UniversityRecruiting
-
Faculty Sao Leopoldo Mandic CampinasUnknown
-
Ocean Spray Cranberries, Inc.Recruiting
-
University of California, San FranciscoMount Zion Health Fund; Miracle Fruit FarmRecruitingHead and Neck Cancer | Taste DysfunctionUnited States
-
Chonbuk National University HospitalCompletedFunctional ConstipationKorea, Republic of
-
Sheikh Zayed Federal Postgraduate Medical InstituteFatima Jinnah Dental CollegeCompletedMouth Diseases | Gingivitis
-
Unilever R&DCompleted
-
Dr. D. Y. Patil Dental College & HospitalRecruiting
-
PepsiCo Global R&DCompletedGlycemic IndexUnited States